|
Name |
4-Methyl-6-nitroquinolin-2-ol
|
Molecular Formula | C10H8N2O3 | |
IUPAC Name* |
4-methyl-6-nitro-1H-quinolin-2-one
|
|
SMILES |
CC1=CC(=O)NC2=C1C=C(C=C2)[N+](=O)[O-]
|
|
InChI |
InChI=1S/C10H8N2O3/c1-6-4-10(13)11-9-3-2-7(12(14)15)5-8(6)9/h2-5H,1H3,(H,11,13)
|
|
InChIKey |
QBBNQTCDZWMPAH-UHFFFAOYSA-N
|
|
Synonyms |
4-methyl-6-nitroquinolin-2-ol; 90771-17-8; 4-methyl-6-nitro-1H-quinolin-2-one; 4-Methyl-6-nitro-2(1H)-quinolinone; 2-Hydroxy-4-methyl-6-nitroquinoline; CBMicro_033436; Cambridge id 5796050; Oprea1_082474; Oprea1_318868; SCHEMBL5909911; CHEMBL1886151; DTXSID80346059; ALBB-005438; ZINC9461262; BBL013251; MFCD01014320; STK503410; STK736439; 4-methyl-6-nitroquinolin-2(1H)-one; AKOS000264872; AKOS003388296; SB68740; NCGC00188260-01; 4-Methyl-6-nitro-2(1H)-quinolinone #; VS-03721; BIM-0033578.P001; BB 0260320; CS-0257735; 1,2-dihydro-4-methyl-6-nitro-2-oxo quinoline; 1,2-Dihydro-4-methyl-6-nitro-2-oxoquinoline; D84402; EN300-6763387; 4-METHYL-6-NITRO-1,2-DIHYDROQUINOLIN-2-ONE; Z57464802
|
|
CAS | 90771-17-8 | |
PubChem CID | 609262 | |
ChEMBL ID | CHEMBL1886151 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.18 | ALogp: | 1.1 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.572 |
Caco-2 Permeability: | -4.646 | MDCK Permeability: | 0.00009520 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.404 | Plasma Protein Binding (PPB): | 88.69% |
Volume Distribution (VD): | 0.607 | Fu: | 6.24% |
CYP1A2-inhibitor: | 0.967 | CYP1A2-substrate: | 0.865 |
CYP2C19-inhibitor: | 0.311 | CYP2C19-substrate: | 0.084 |
CYP2C9-inhibitor: | 0.057 | CYP2C9-substrate: | 0.706 |
CYP2D6-inhibitor: | 0.058 | CYP2D6-substrate: | 0.482 |
CYP3A4-inhibitor: | 0.066 | CYP3A4-substrate: | 0.146 |
Clearance (CL): | 5.385 | Half-life (T1/2): | 0.431 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.573 |
Drug-inuced Liver Injury (DILI): | 0.906 | AMES Toxicity: | 0.981 |
Rat Oral Acute Toxicity: | 0.177 | Maximum Recommended Daily Dose: | 0.728 |
Skin Sensitization: | 0.92 | Carcinogencity: | 0.885 |
Eye Corrosion: | 0.062 | Eye Irritation: | 0.968 |
Respiratory Toxicity: | 0.95 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000798 | 0.351 | D0T5WK | 0.329 | ||||
ENC001539 | 0.351 | D0J9ZR | 0.324 | ||||
ENC000034 | 0.340 | D0CP4E | 0.321 | ||||
ENC001364 | 0.315 | D0W2NM | 0.313 | ||||
ENC004685 | 0.288 | D0Y7PG | 0.301 | ||||
ENC000118 | 0.281 | D0A1DH | 0.291 | ||||
ENC002926 | 0.275 | D0IT2X | 0.288 | ||||
ENC005178 | 0.274 | D0I8DD | 0.277 | ||||
ENC000178 | 0.273 | D0SN9T | 0.273 | ||||
ENC005445 | 0.273 | D05HFY | 0.270 |